Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)

(2011) T. H. Jones et al.   DIABETES CARE

Polymorphisms of Fractalkine Receptor CX3CR1 Gene in Patients with Symptomatic and Asymptomatic Carotid Artery Stenosis

(2011) Maria Kimouli et al.   Journal of Atherosclerosis and Thrombosis

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

(2010) Svetlana Y. Kalinchenko et al.   CLINICAL ENDOCRINOLOGY

Androgen Receptor-Dependent and Independent Atheroprotection by Testosterone in Male Mice

(2010) Johan Bourghardt et al.   ENDOCRINOLOGY

Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice

(2009) Mei Ni et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process

(2009) T. Hugh Jones et al.   ATHEROSCLEROSIS

Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice

(2008) Christophe Combadière et al.   CIRCULATION

Characterisation of Fractalkine/CX3CL1 and Fractalkine Receptor (CX3CR1) Expression in Abdominal Aortic Aneurysm Disease

(2008) A. Patel et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY